Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

NCT00350272 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Elvucitabine
DRUG: Lamivudine
DRUG: Tenofovir
DRUG: Efavirenz

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

[object Object]